2.90
3.65%
-0.11
Pasithea Therapeutics Corp Stock (KTTA) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Selling, General, and Administrative
|
27.51%
2.2916
|
1.7972 | 2.1646 | 1.8005 | 2.1163 |
Operating Income/Loss |
21.52%
-4.0408
|
-5.1488 | -3.7893 | -3.8287 | -3.2126 |
Nonoperating Income/Loss |
0.1799
|
- | - | - | - |
Income/Loss From Continuing Operations Before Tax |
23.26%
-3.8608
|
-5.0313 | -3.6126 | -3.5981 | -3.2658 |
Income/Loss From Continuing Operations After Tax |
23.26%
-3.8608
|
-5.0313 | -3.6126 | -3.5981 | -3.2658 |
Net Income/Loss
|
23.52%
-3.8608
|
-5.0482 | -3.6126 | -3.7632 | -3.5377 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
104.25%
1.0425
|
-24.56 | 25.16 | 26.13 | 26.07 |
Diluted Average Shares |
104.25%
1.0425
|
-24.56 | 25.16 | 26.13 | 26.07 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):